How to improve linkage between patients and treatment?
<Hepatology Digest>: After a positive HCV screen, how can we effectively link patients to treatment services and overcome potential barriers?
Over 8500 representatives from 85 countries attended AASLD 2023
<Hepatology Digest>: How many attendees are gathered together for the meeting from all over the world? What percentage of the participants are from the Asia Pacific region?
How do healthcare professionals provide personalized care and support?
<Hepatology Digest>: How can caregivers provide personalized care and support to meet the specific needs of patients with MASLD?
Combination locoregional therapy with systemic therapy for intermediate and advanced stage HCC
<Hepatology Digest>: How does the combination locoregional therapy with systemic therapy improve the prognosis and survival rates for patients with intermediate and advanced stage HCC, and what are the synergistic effects…
The main mechanisms and strategies of HCC combination therapy
<Hepatology Digest>: What is the specific efficacy of combination therapies in improving tumor response in HCC, and how can the optimal treatment combinations and timing be determined?
The focus of scientific research in MASLD
<Hepatology Digest>: What are the current research focuses on metabolic-associated fatty liver disease? What are the key scientific questions that need further exploration?
What new concepts and methods have gut microbiome research brought to the diagnosis and treatment of autoimmune liver disease?
<Hepatology Digest>: How can studying the microbiome provide new insights and methods for the diagnosis, prevention, and treatment of autoimmune liver diseases?
How to improve HCV screening?
<Hepatology Digest>: Which populations should priority be given for HCV screening, and how can we improve screening rates to ensure early detection and treatment?
The main highlights of 2023 AASLD Annual Meeting
<Hepatology Digest>: What are the main highlights of this Annual Meeting? Is it very different from the previous two ones？
How can patients perceive and actively manage MASLD on their own?
<Hepatology Digest>: How can patients perceive and actively manage MASLD on their own to alleviate the condition and avoid further deterioration?